---
figid: PMC3965173__nihms559453f1
figlink: /pmc/articles/PMC3965173/figure/F1/
number: Figure 1
caption: Signaling pathways that can be inhibited to increase the radiation response
  of tumors. Activation of growth factor receptors including EGFR leads to upregulation
  of numerous downstream pathways. One of these, the PI3K/Akt pathway, has been implicated
  in radioresistance and in the regulation of hypoxia-inducible factor 1α (HIF-1α)
  and vascular endothelial growth factor (VEGF) expression. Inhibition of the PI3K/Akt
  pathway has been shown to increase the intrinsic radiosensitivity of cancer cells.
  However, recent evidence suggests that inhibition of the EGFR/PI3K/Akt pathway can
  also increase the extrinsic radiosensitivity of tumors by altering the tumor microenvironment,
  perhaps by improving blood flow and tumor oxygenation.
pmcid: PMC3965173
papertitle: Modulating the tumor microenvironment to increase radiation responsiveness.
reftext: Jayashree Karar, et al. Cancer Biol Ther. ;8(21):1994-2001.
pmc_ranked_result_index: '2922'
pathway_score: 0.9405811
filename: nihms559453f1.jpg
figtitle: Signaling pathways that can be inhibited to increase the radiation response
  of tumors
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3965173__nihms559453f1.html
  '@type': Dataset
  description: Signaling pathways that can be inhibited to increase the radiation
    response of tumors. Activation of growth factor receptors including EGFR leads
    to upregulation of numerous downstream pathways. One of these, the PI3K/Akt pathway,
    has been implicated in radioresistance and in the regulation of hypoxia-inducible
    factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF) expression. Inhibition
    of the PI3K/Akt pathway has been shown to increase the intrinsic radiosensitivity
    of cancer cells. However, recent evidence suggests that inhibition of the EGFR/PI3K/Akt
    pathway can also increase the extrinsic radiosensitivity of tumors by altering
    the tumor microenvironment, perhaps by improving blood flow and tumor oxygenation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BAD
  - MAPK1
  - PGF
  - EGFR
  - MAPK3
  - AKT1
  - VEGFB
  - AKT3
  - VEGFD
  - FOXO1
  - VEGFA
  - MTOR
  - RAF1
  - PIK3R3
  - PTEN
  - GSK3A
  - GSK3B
  - VEGFC
  - RBMS1
  - ARAF
  - AKT2
  - PIK3CG
  - STAT6
  - STAT5B
  - MAP2K1
  - MAP2K2
  - STAT1
  - PDK1
  - HRAS
  - STAT3
  - EIF4EBP1
  - JAK1
  - JAK2
  - JAK3
  - KRAS
  - STAT4
  - TYK2
  - PIK3R5
  - PIK3CA
  - NRAS
  - BRAF
  - STAT5A
  - STAT2
  - PIK3CD
  - PIK3R6
  - PIK3CB
  - PIK3R4
  - LY294002
  - Amprenavir
  - Temsirolimus
  - AZD2171
  - cediranib
  - Deforolimus
  - NVP-BEZ235
  - Rapamycin
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: BAD
  symbol: BAD
  source: hgnc_symbol
  hgnc_symbol: BAD
  entrez: '572'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: FKHR
  symbol: FKHR
  source: hgnc_prev_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: GSK3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: YC1
  symbol: YC1
  source: hgnc_alias_symbol
  hgnc_symbol: RBMS1
  entrez: '5937'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: 4E-BP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K)
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
chemicals:
- word: LY294002
  source: MESH
  identifier: C085911
- word: Amprenavir
  source: MESH
  identifier: C095108
- word: Temsirolimus
  source: MESH
  identifier: C401859
- word: AZD2171
  source: MESH
  identifier: C500926
- word: cediranib
  source: MESH
  identifier: C500926
- word: Deforolimus
  source: MESH
  identifier: C515074
- word: NVP-BEZ235
  source: MESH
  identifier: C531198
- word: Rapamycin
  source: MESH
  identifier: D020123
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
